(Q51543749)

6 April 2018

title

Integrating cell-level kinetic modeling into the design of engineered protein therapeutics. (English)

1 reference

6 April 2018

main subject

protein design

0 references

author

Douglas A. Lauffenburger

series ordinal

2

object named as

Douglas A Lauffenburger

1 reference

6 April 2018

Balaji M Rao

1

1 reference

6 April 2018

K Dane Wittrup

series ordinal

3

1 reference

6 April 2018

publication date

1 February 2005

1 reference

6 April 2018

published in

Nature Biotechnology

1 reference

6 April 2018

volume

23

1 reference

6 April 2018

issue

2

1 reference

6 April 2018

page(s)

191-194

1 reference

6 April 2018

The use and analysis of microarray data

cites work

1 reference

Computational modeling of the EGF-receptor system: a paradigm for systems biology

21 January 2018

1 reference

Status of epidermal growth factor receptor antagonists in the biology and treatment of cancer

21 January 2018

1 reference

Engineering epidermal growth factor for enhanced mitogenic potency

21 January 2018

1 reference

Rational cytokine design for increased lifetime and enhanced potency using pH-activated "histidine switching".

21 January 2018

1 reference

Therapeutic antibodies for human diseases at the dawn of the twenty-first century

21 January 2018

1 reference

21 January 2018

Etanercept: An overview

1 reference

VEGF-Trap: a VEGF blocker with potent antitumor effects

21 January 2018

1 reference

Growth hormone binding affinity for its receptor surpasses the requirements for cellular activity

21 January 2018

1 reference

Mathematical model of human growth hormone (hGH)-stimulated cell proliferation explains the efficacy of hGH variants as receptor agonists or antagonists

21 January 2018

1 reference

Kinetic and affinity limits on antibodies produced during immune responses

21 January 2018

1 reference

Cell-level pharmacokinetic model of granulocyte colony-stimulating factor: implications for ligand lifetime and potency in vivo.

21 January 2018

1 reference

Computational model for effects of ligand/receptor binding properties on interleukin-2 trafficking dynamics and T cell proliferation response.

21 January 2018

1 reference

Cell growth signal transduction is quantal

21 January 2018

1 reference

CD4 enhances T cell sensitivity to antigen by coordinating Lck accumulation at the immunological synapse

21 January 2018

1 reference

An amplified sensitivity arising from covalent modification in biological systems

21 January 2018

1 reference

Sniffers, buzzers, toggles and blinkers: dynamics of regulatory and signaling pathways in the cell

21 January 2018

1 reference

Computational modeling of the dynamics of the MAP kinase cascade activated by surface and internalized EGF receptors

21 January 2018

1 reference

Construction of a genetic toggle switch in Escherichia coli

21 January 2018

1 reference

Detection of multistability, bifurcations, and hysteresis in a large class of biological positive-feedback systems

21 January 2018

1 reference

Current methods for the generation of human antibodies for the treatment of autoimmune diseases

21 January 2018

1 reference

Synergistic interactions of antibodies in rate of virus neutralization

21 January 2018

1 reference

Optimization of protein therapeutics by directed evolution

21 January 2018

1 reference

Interrupting autocrine ligand-receptor binding: comparison between receptor blockers and ligand decoys

21 January 2018

1 reference

Transport of molecules, particles, and cells in solid tumors

21 January 2018

1 reference

Darbepoetin alfa has a longer circulating half-life and greater in vivo potency than recombinant human erythropoietin

21 January 2018

1 reference

The pharmacological basis of anti-IgE therapy

21 January 2018

1 reference

High amounts of circulating interleukin (IL)-6 in the form of monomeric immune complexes during anti-IL-6 therapy. Towards a new methodology for measuring overall cytokine production in human in vivo.

21 January 2018

1 reference

Effect of pegylation on pharmaceuticals

21 January 2018

1 reference

Immunoadhesins as research tools and therapeutic agents

21 January 2018

1 reference

Albumin binding as a general strategy for improving the pharmacokinetics of proteins

21 January 2018

1 reference

IL-15Ralpha recycles and presents IL-15 In trans to neighboring cells

21 January 2018

1 reference

Strategies to treat and prevent the development of neutralizing anti-interferon-β antibodies

21 January 2018

1 reference

Bioequivalence and the immunogenicity of biopharmaceuticals

21 January 2018

1 reference

Targeted systemic therapy of prostate cancer with a monoclonal antibody to prostate-specific membrane antigen

21 January 2018

1 reference

Protein engineering by cell-surface display

21 January 2018

1 reference

Rational design and engineering of therapeutic proteins

21 January 2018

1 reference

Designing proteins for therapeutic applications

21 January 2018

1 reference

In silico models for cellular and molecular immunology: successes, promises and challenges.

21 January 2018

1 reference

Modelling viral and immune system dynamics

21 January 2018

1 reference

Introductory science and mathematics education for 21st-Century biologists

21 January 2018

1 reference

Advances in biomedical engineering

21 January 2018

1 reference

A simple physical model for binding energy hot spots in protein-protein complexes

21 January 2018

1 reference

Inactivation of TNF signaling by rationally designed dominant-negative TNF variants

21 January 2018

1 reference

Scratching the (cell) surface: cytokine engineering for improved ligand/receptor trafficking dynamics

21 January 2018

1 reference

Realism in drug discovery-could Cassandra be right?

21 January 2018

1 reference

7 January 2021

Complex disease and the new clinical sciences

1 reference

7 January 2021

A model-based approach for the optimization of radioimmunotherapy through antibody design and radionuclide selection

1 reference

7 January 2021

A rational design strategy for protein hormone superagonists

1 reference

7 January 2021

Identifiers

DOI

10.1038/NBT1064

1 reference

6 April 2018

1 reference

6 April 2018